mediated through MC4R Cardiovascular : Reports of blood pressure changes, particularly with higher doses Erections : Spontaneous erections in male users, particularly during initial dosing Injection site : Reactions common with subcutaneous administration Regulatory warnings : TGA (Australia), EMA, and other agencies have issued warnings about unregulated MT-2 use PT-141 Side Effects# PT-141's side effect profile is better characterized through Phase 3 data: Nausea : Most common adverse event (~40% of patients in trials)
Telehealth companies like Hims & Hers and Noom began selling copies of the popular weight-loss drugs while they were in shortage but were supposed to stop selling them at scale when supply issues waned earlier this year
Recently, a newly founded bifunctional enzyme GshF from Actinobacillus succinogenes had be discovered in our lab
Gorrieri G, Scudieri P, Caci E, Schiavon M, Tomati V, Sirci F, Napolitano F, Carrella D, Gianotti A, Musante I, et al
10.1016/S0027-5107(01)00091-4
Favorable lean mass preservation (only 21.9% of weight loss from lean mass) is a potential safety/tolerability advantage